drugset / Trial / NCT05079243
Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections
Unknown
5 enrolled
Stemform
Aleris-Hamlet Hospitaler København · collabRigshospitalet, Denmark · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
Investigate the effect of dermal/subcutaneous injection of ASC enriched fat transplant in a protective natural scaffold, designed to sustain the ASC viability after dermal/subcutaneous injection.
Timeline
- Start
- 2021-06-04
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose derived stromal cells | Cell therapy | — | Other |
| Subject | Scaffold and adipose-derived stromal cell enriched fat grafts | Other / unclassified | — | Other |
| Subject | fat grafts | Other / unclassified | — | Other |
Indications
No indication recorded.